pocketful logo
RPG Life Sciences Ltd logo

RPG Life Sciences Ltd

NSE: RPGLIFE BSE: 532983

1881

(-0.32%)

Sat, 11 Apr 2026, 05:06 am

RPG Life Sciences Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    3131.08

  • Net Profit

    183.24

  • P/B

    7.10

  • Sector P/E

    31.77

  • P/E

    20.56

  • EV/EBITDA

    14.17

  • Debt/Equity (Industry)

    0.23

  • Interest Cover (Industry)

    9.71

  • ROCE (Industry)

    13

  • RONW (Industry)

    12.31

  • ROE

    25.53

  • ROCE

    32.28

  • Debt/Equity

    0

  • EPS (TTM)

    54.87

  • Dividend Yield

    1.27

  • Book Value

    10.03

  • Interest Cover

    93.37

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are thoroughly covered by earnings (7.3x coverage).
  • RPG Life Sciences's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • RPG Life Sciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • RPG Life Sciences is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • RPG Life Sciences's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • Yugal Kishor's remuneration is higher than average for companies of similar size in India.
  • RPG Life Sciences is not covered by any analysts.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters72.9572.9572.9572.9572.95
FII1.001.111.351.451.30
DII7.046.706.486.146.06
Public19.0119.2419.2219.4619.69
Government00000

Read More

Technical Analysis

RSI

48.59

MACD

-12.12

50 DMA

1916.31

200 DMA

2243.80

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2362.572110.571984.131858.571732.131606.571354.57
Fibonacci2110.572014.301954.831858.571762.301702.831606.57
Camarilla19271903.901880.801858.571834.601811.501788.40

Pivots Level: Classic

R3

+504

2362.57

R2

+252

2110.57

R1

+125.57

1984.13

1858.57
1858.57
Pivot Point
LTP: 1881

S1

-126.43

1732.13

S2

-252

1606.57

S3

-504

1354.57

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1880.78

  • 20-EMA

    1883.73

  • 30-EMA

    1899.96

  • 50-EMA

    1948.18

  • 100-EMA

    2052.18

  • 200-EMA

    2139.17

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
27 Jan 2026board-meetingsQuarterly Results
14 Jun 2025agm
27 May 2025dividendFinal Dividend - Rs. - 2027 Jun 2025
28 Apr 2025dividend₹20.00 Dividend /Share27 Jun 2025
11 Jun 2024agm
28 May 2024dividendFinal Dividend - Rs. - 1628 Jun 2024
30 Apr 2024dividend₹16.00 Dividend /Share28 Jun 2024
07 Jul 2023agm
21 Jun 2023dividendFinal Dividend - Rs. - 1221 Jul 2023
28 Apr 2023dividend₹12.00 Dividend /Share21 Jul 2023

Read More

Peer Comparison

RPG Life Sciences Ltd logo

RPG Life Sciences Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Lupin Ltd logo

Lupin Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

RPG Life Sciences Ltd About

RPG Life Sciences is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2007

Headquarters

CEO

H V Goenka

Employees

Contact

Website icon

Website

http://www.rpglifesciences.com

Email icon

Email

info@rpglifesciences.com

Phone icon

Phone

91-022-24981650

Location icon

Location

RPG House, 463 Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030

Read More

RPG Life Sciences Ltd Company History

YearHistory
2013
  • RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility
  • RPG Life Sciences bagged 'Asia's Best Employer Brand Awards 2013' in Singapore.
2014
  • Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014.
2015
  • RPG Life Plans Skincare Foray
2016
  • RPG Life Sciences announces foray into Cosmetic Industry
  • RPG Life Sciences to expand its formulations business
  • RPG Life gains over 14 percent on getting EUGMP certification
2019
  • RPG Life Sciences enters Anti-Diabetic therapeutic area.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
XTX MARKETS LLPSell136929731.4721 Sept 2021
XTX MARKETS LLPBuy135708730.5321 Sept 2021
XTX MARKETS LLPSell85613597.0803 Sept 2021
XTX MARKETS LLPBuy8962459603 Sept 2021
XTX MARKETS LLPBuy162323566.9101 Sept 2021
XTX MARKETS LLPSell159973568.0901 Sept 2021
M/S MENTOR CAPITAL LIMITEDSell327584294.3106 Jan 2020
AUTHUM INVESTMENT & INFRASTRUCTURE LIMITEDBuy327584294.3106 Jan 2020
NUCLEUS LIFE TRUSTBuy161000279.101 Aug 2018
CHATTARPATI APARTMENTS LLPSell161000279.101 Aug 2018

Read More

RPG Life Sciences Ltd News

RPG Life Sciences Submits SEBI Compliance Certificate

RPG Life Sciences submitted certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 2026, confirming compliance with dematerialisation requirements.

09 Apr 2026

equity-markets

RPG Life Sciences Opens Special Window for Share Transfer

RPG Life Sciences announces special window for transfer and dematerialisation of physical securities sold/purchased before April 1, 2019, valid from February 5, 2026 to February 4, 2027.

07 Apr 2026

equity-markets

RPG Life Sciences Reports Strong API Performance

RPG Life Sciences indicates robust January performance for API segment with strong domestic portfolio showing positive momentum according to CNBC-TV18 coverage.

28 Jan 2026

stocks

RPG Life Sciences Q3 Results Show Mixed Performance

RPG Life Sciences reported Q3 net profit of ₹221 million, down from ₹350 million YoY, while revenue increased to ₹1.8 billion from ₹1.72 billion in the same period last year.

27 Jan 2026

co actions results

RPG Life Sciences Receives ₹1.08 Cr GST Demand Order

RPG Life Sciences received GST order from Maharashtra State Tax Officer demanding ₹1.08 crores for tax period April 2021 to March 2022. Company plans to contest the demand through legal remedies.

29 Dec 2025

stocks

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800